Novavax Researcher Says No Chance Of A 'Shortcut' In Vaccine Safety
Vaccine maker Novavax is starting a large coronavirus vaccine trial in the U.K. Gregory Glenn, the company's president of research and development, talks with NPR about how vaccines are tested.
Read more on NPR
Thứ Bảy, 26 tháng 9, 2020
Đăng ký:
Đăng Nhận xét (Atom)
0 nhận xét:
Đăng nhận xét